Arcutis Biotherapeutics Inc (ARQT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,141 | -140,039 | -262,140 | -311,458 | -206,356 |
| Depreciation Amortization | 2,573 | -4,942 | -6,239 | -1,319 | 3,908 |
| Accounts receivable | -73,163 | -47,259 | -17,349 | -8,458 | 0 |
| Accounts payable and accrued liabilities | -1,694 | 2,229 | 3,152 | 1,565 | 245 |
| Other Working Capital | -34,829 | -15,080 | -23,501 | -10,175 | 3,620 |
| Other Operating Activity | 117,629 | 92,933 | 59,020 | 72,130 | 23,956 |
| Operating Cash Flow | $-5,625 | $-112,158 | $-247,057 | $-257,715 | $-174,627 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -19,567 | 33,963 | 180,660 | -63,916 | -74,958 |
| PPE Investments | -686 | -143 | -428 | -15,783 | -995 |
| Purchase Sale Intangibles | -10,000 | -5,000 | N/A | -7,500 | N/A |
| Other Investing Activity | -10,000 | -5,000 | 0 | -7,500 | 0 |
| Investing Cash Flow | $-30,253 | $28,820 | $180,232 | $-87,199 | $-75,953 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 125,000 | 73,987 |
| Debt Repayment | 0 | -100,000 | 0 | N/A | N/A |
| Common Stock Issued | 6,973 | 166,202 | 98,187 | 164,530 | 209,597 |
| Other Financing Activity | 0 | 0 | 3,136 | 12,268 | -1,637 |
| Financing Cash Flow | $6,973 | $66,202 | $101,323 | $301,798 | $281,947 |
| Exchange Rate Effect | 168 | -235 | -50 | 0 | N/A |
| Beginning Cash Position | 71,952 | 89,323 | 54,875 | 97,991 | 66,624 |
| End Cash Position | 43,215 | 71,952 | 89,323 | 54,875 | 97,991 |
| Net Cash Flow | $-28,737 | $-17,371 | $34,448 | $-43,116 | $31,367 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,625 | -112,158 | -247,057 | -257,715 | -174,627 |
| Capital Expenditure | -686 | -143 | -428 | -15,783 | -995 |
| Free Cash Flow | -6,311 | -112,301 | -247,485 | -273,498 | -175,622 |